Actigraphy supports fezolinetant sleep improvements by week 4

Marla Shapiro, MDCM, explains how OPTION-VMS actigraphy data corroborated patient-reported sleep improvements with fezolinetant (Veozah) as early as week 4. For more menopause-related content, see: https://www.contemporaryobgyn.net/cli...